NORWOOD, Mass., April 27, 2023 /PRNewswire/ -- Entrinsic Bioscience is pleased to announce the upcoming poster session on the role of Enterade® Advanced Oncology Formula in reducing adverse gastrointestinal side effects for patients undergoing cancer treatment. The event will showcase the preliminary results of an ongoing clinical study that is being conducted by a team of researchers and practitioners from Baptist Health Louisville Cancer Care in Louisville, Kentucky.